Blocking HIF signaling via novel inhibitors of CA9 and APE1/Ref-1 dramatically affects pancreatic cancer cell survival.
- DOI
- 10.1038/s41598-018-32034-9
- Published
- 2018 Sep 13
- Container
- Scientific reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41598-018-32034-9,
title = {Blocking HIF signaling via novel inhibitors of CA9 and APE1/Ref-1 dramatically affects pancreatic cancer cell survival.},
author = {Logsdon DP and Shah F and Carta F and Supuran CT and Kamocka M and Jacobsen MH and Sandusky GE and Kelley MR and Fishel ML},
year = {2018},
journal = {Scientific reports},
doi = {10.1038/s41598-018-32034-9},
url = {https://doi.org/10.1038/s41598-018-32034-9}
}RIS
TY - JOUR TI - Blocking HIF signaling via novel inhibitors of CA9 and APE1/Ref-1 dramatically affects pancreatic cancer cell survival. AU - Logsdon DP AU - Shah F AU - Carta F AU - Supuran CT AU - Kamocka M AU - Jacobsen MH AU - Sandusky GE AU - Kelley MR AU - Fishel ML PY - 2018 JO - Scientific reports DO - 10.1038/s41598-018-32034-9 UR - https://doi.org/10.1038/s41598-018-32034-9 ER -
APA
DP, L., F, S., F, C., CT, S., M, K., MH, J., GE, S., MR, K., & ML, F. (2018). Blocking HIF signaling via novel inhibitors of CA9 and APE1/Ref-1 dramatically affects pancreatic cancer cell survival.. Scientific reports. https://doi.org/10.1038/s41598-018-32034-9
Source records
- pubmed · retrieved 2026-09-26T00:51:22.991Z